Consequently, we demonstrated that CC12 suppressed the proliferation and oncogenic phenotypes of GBM in vitro and in vivo GBM-bearing tumor xenograft mice via target inhibition of the Lyn signaling network. The gene discussed is LYN; the disease is glioblastoma.